An Evaluation of a Training Program in Restraint-Free Care for Individuals with Dementia Christina Garrison-Diehn, Clair Rummel, & Jane E.

Similar documents
Management of the Acutely Agitated Long Term Care Patient

Describe the University of Nevada, Reno Nevada

Where PASRR and Dementia Meet

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Antipsychotic Medications

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

The place for treatments of associated neuropsychiatric and other symptoms

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

How I Treat Aggression in Outpatients With Dementia. C. Omelan MD, FRCP(C)

Psychosis and Agitation in Dementia

NKR 55 demens og medicin PICO 2 seponering af antipsykotisk medicin versus forsat behandling Review information

Behavioral and Psychological Symptoms of dementia (BPSD)

The burden of psychotropic drug prescribing in people with dementia: a population database study

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

NeuroPharmac Journal ISSN: Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M.

Management of Agitation in Dementia. Kimberly Triplett Ferguson, MS4

Behavior Problems: in Long Term Care and Assisted Living

Management of Behavioral Problems in Dementia

Best Practice Guideline for Accommodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?

Re: Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care

Behavioural and Psychological Symptoms and Medications Presentation

Vanderbilt & Qsource Webinar Series

Antipsychotics for Dementia Under Control or Over-Prescribed?

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

Silvia Duong, 1,2 Kam-Tong Yeung, 1 and Feng Chang 1,3. 1. Introduction

Integrating INTERACT into Interim Pharmacist Reviews

Reducing Antipsychotic Drug Use in Long Term Care

The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature

Risks of Antipsychotics use In Dementia

Delirium. Assessment and Management

Caregiver Mediated Intervention. Trumps Pharmacotherapy for BPSD

Recognition and Management of Behavioral Disturbances in Dementia

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

Critical Care Pharmacological Management of Delirium

Antipsychotic use in dementia: a systematic review of benefits and risks from metaanalyses

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease

Pharmacological Treatment of Aggression in the Elderly

GERIATRIC ADULT MENTAL HEALTH SPECIALTY TEAM TRAINING MODULES

Evidence-Based Interventions to Improve Caregiver and Patient Outcomes in Dementia

Delirium. Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL

PSYCHOTROPIC SOLUTIONS

Cambridge University Press Effective Treatments in Psychiatry Peter Tyrer and Kenneth R. Silk Excerpt More information

PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES

MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE

Critical Care Pharmacological Management of Delirium

Challenging ASD Cases November 11, Melanie Penner, MD, MSc, Mohammad Zubairi, MD, MEd,

9/11/2012. Clare I. Hays, MD, CMD

Dementia: Rethinking our approach to behaviour

Amanda Adams-Fryatt RN MN Nurse Practitioner WRHA

Atypical Antipsychotics and the Risk of Diabetes in an Elderly Population in Long-Term Care: A Retrospective Nursing Home Chart Review Study

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016

Psychotropic Medication. Including Role of Gradual Dose Reductions

Improving Meaningful Engagement (ME) in LTC Residents with Dementia: Applying the MemPics Program

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

DELIRIUM IN ICU: Prevention and Management. Milind Baldi

Medications for treating people with dementia: summary of evidence on cost-effectiveness

Why is training not enough to make a difference in dementia care? Acknowledgements. Staff attitudes need to encourage:

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document.

Workshop cases answers

MENTAL HEALTH DISEASE CLASSIFICATIONS

According to the U.S. Department of Health and Human

CEPP National Audit Antipsychotics in Dementia

Basic Standards for Residency/Fellowship Training in Geriatric Psychiatry

Dementia Support Across the Care Continuum

Test your Knowledge: Recognizing Delirium

Neuropsychiatric Syndromes

CHCS. Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia. Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES

12/17/2012. Unnecessary Drugs

Opinion statement. Introduction. Cognitive Disorders (M Geschwind, Section Editor)

Delirium. Approach. Symptom Update Masterclass:

Pharmacists as a vital part of the mental health of the nation

Delirium in the Elderly

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal

Delirium in the Elderly

Treatment of behavioral and psychological symptoms of dementia: a systematic review

Psychotropic Medication Use in Canadian Long-Term Care Patients Referred for Psychogeriatric Consultation

Delirium, Depression and Dementia

Depression in the Eldery Handout Package

Management of Behavioral and Psychological Symptoms in People with Dementia Living in Care Homes: A UK Perspective

APNA 25th Annual Conference October 21, Session 3014

Marita P. McCabe a *,MichaelBird b, Tanya E. Davison c, David Mellor a, Sarah MacPherson d, David Hallford a and Melissa Seedy a

JBI Database of Systematic Reviews & Implementation Reports 2014;12(9)

Across the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs

Presenter: Dr M. Elizabeth Collerson Health Law Research Program Queensland University of Technology

An#psycho#c Medica#on in People with Demen#a

Supporting people with dementia to live well in London care homes

Older People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director

GEC Delirium Resource Review Form

Research Journal of Pharmaceutical, Biological and Chemical Sciences

TRANSPARENCY COMMITTEE Opinion 19 February 2014

Delirium. Dr. John Puxty

Transcription:

An Evaluation of a Training Program in Restraint-Free Care for Individuals with Dementia Christina Garrison-Diehn, Clair Rummel, & Jane E. Fisher

Background Disease. (Xu, Kochanek & Tejada-Vera, 2009) Dementia is the leading cause of nursing home admission (Eaker, Vierkant, & Mickel, 2002). 70% of individuals with dementia are living in a nursing home at the end of their life (Mitchell, Kiely & Hamel, 2005) Top reasons for nursing home placement: (Buhr, Kuchibhatla & Clipp, 2006) Need for more skilled care Dementia related behaviors

Background Behavioral challenges: Agitation Aggression Delusional speech Hallucinations Repetitive vocalizations Wandering Depressed affect Social withdrawal Prevalence rates = over 60% (Lyketsos, et al. 2002).

Traditional Model of Dementia Behavioral challenges = symptoms of neuropathology Attribution of behavioral disturbances as a symptoms of dementia increases the risk of excess disability Impairment in function beyond that which can be accounted for by the disease. (Dawson, Wells & Kline, 1993) Frequency of adaptive behavior is diminished prematurely. (Fisher et al.,2007) First line of treatment: antipsychotic medications

Antipsychotics Most common treatment = antipsychotic medications Prescribed off-label 32-58% of nursing home residents are prescribed antipsychotics (Ronchon et al., 2007; Margallo-Lana et al., 2001; Kamble et al., 2009) Typical: haloperidol, thorazine Atypical: risperidone, olanzapine Moderate evidence of efficacy (Agency of Healthcare Research and Quality, 2007)

Antipsychotics Adverse effects offset the advantages (Ballard et al., 2009; Schneider et al., 2006; Ballard & Waite, 2006). Increased risk of: Mortality Cerebrovascular adverse events Extrapyramidal symptoms Upper respiratory infections Sedation & confusion Premature reduction of adaptive functioning Decreased quality of life (Ballard & Margallo-Lana, 2004)

Contextual Model of Dementia Behavioral challenges = inability to report private events & have needs met (Fisher et al., 2007) Behavior communicates what words cannot Intervention = medical assessment + environmental assessment Evidence for contextual model: modification of the social and physical environment results in a reduction of these problems and a reduction in excess disability (Yury & Fisher, 2007; Burgio & Stevens, 1999; Buchanan & Fisher, 2002; Cohen-Mansfield & Werner, 1998).

Restraint Free Care Training Program Development Quality and Compliance Goals: 1. Increase staff knowledge of evidence-based practices for dementia care. 2. Reduce the use of psychotropic medications to manage behavioral challenges in residents with dementia. 3. Increase facilities ability to keep challenging residents. 4. Improve quality of life for residents with dementia by reducing excess disability and preserving adaptive functioning.

Restraint Free Care Training Program Development Program characteristics Available to long-term care facilities on a voluntary basis No cost to the facility Needs assessment conducted pre-training Train-the-trainer model 10 hours of training Consultation services post-training Aid in providing trainings to full staff Behavioral consultation for challenging cases Satisfied state requirement for dementia training

Restraint Free Care Training Program Overview Topics Covered: Stress of Dementia Care Communication Techniques Excess Disability Assessing Pain Delirium Depression Promoting Choice Delusions and Hallucinations Sexuality Behavioral Interventions Structured trainings designed to include idiographic examples from each specific facility throughout the trainings

Program Timeline Development & Recruitment Trainings Conducted January 2010 April 2010 May 2010 November 2010 Data Collection Through April 2011

Facility Characteristics Facility Type Skilled Nursing Group Home N Residents on Antipsychotic Medication Pre Training Residents on Antianxiety medication Pre Training 8 <10% - 60% 10% - 50% 12 <10% - 100% <10% - 80%

Participant Demographics N = 64 Gender: 85% Female Education: High School: 5% 9% 30% Asian African American Hispanic Some College: 17% AA: 17% BA: 38% Masters/Professional: 15% 47% 5% 3% 6% Native Islander Caucasian Unreported

Outcome Measures: Trainers Pre & Post- Training Measures - Modified (ADKS; Carpenter et al., 2009) Approaches to Dementia Questionnaire (ADQ; Lintern et al., 2000 ) Vignette 79-year-old woman Facility resident: 2 years. Recently Mrs. Hansen has been less talkative to her fellow residents and less more frequently and she is refusing to let staff give her a shower.

Outcome Measures Observational Data Collection Two skilled-nursing facilities in Reno, NV Resident criteria Dementia diagnosis Staff report of challenging behaviors Systematic observation of residents Staff behavior and affect when interacting with observed residents Pre- and post-training & post-facility wide training Chart review PRN administration, behavioral incidents, assessments, consults, illness, hospitalizations Medication Administration Records, nursing notes, behavioral reports, incident reports

Outcome Measures 3- Month Follow Up Facility characteristics Antipsychotic medication use Staff turnover Evaluation and feedback form Rate specific training objectives Room for comments Status of facility wide trainings

Pre & Post Results Measure N Pre Post P-value ADKS 40 24.95 25.95.002* ADKS - Contextual 40 4.8 5.13.02* ADQ 30 72.2 73.4.058 Vignette 34 3.21 3.62.12 Vignette - Communication Strategies 34.56.26.02* Vignette Assessment 34 1.01 1.53.005* Vignette - Consultation 34.71.56.08 Vignette Environmental Strategies 34.91 1.26.06

Data Analysis underway Resident behavior + Chart review (staff behavior) Systematic review of impact of training on staff behavior Examining observed changes in adaptive behavior and Versus staff charted behavior Pain assessment Medical assessment Medication administration

Aggregate Observational Data of Staff Facility I IRR trials = 15% Trials Positive Staff Behavior Negative Staff Behavior Positive Affect Negative Affect Neutral Affect Pre 38 84% 12% 87% 5% 16% Post 63 86% 6% 68% 1% 7% 3 month follow-up 48 72% 13% 48% 10% 69% Facility II IRR trials = 45% Trials Positive Staff Behavior Negative Staff Behavior Positive Affect Negative Affect Neutral Affect Pre 84 81% 4% 50% 4% 74% Post 123 84% 16% 49% 3% 49% 3 month follow-up 83 87% 11% 43% 4% 69%

Agreement Facility I Mean Range.885.722 1.0 % agreement.96.90 1.0 Facility II Mean Range.815.688 -.958 % agreement.93.89 -.98

Modules given to full staff Status of Trainings at 3 month follow-up (9 forms received) Managing the stress of dementia care 5 Knowing the facts about dementia 5 Communicating the facts about dementia 5 Knowing about excess disability 5 Assessing pain 4 Promoting choice 4 Making sense of delusions and hallucinations 3 Sexuality in long-term care 3 Ruling out excess disability 3 Ruling out delirium and depression 3 The contextual ABCs of dementia care 2 Searching for clues Part 1: Antecedent interventions 3 Searching for clues Part 2: Consequent Interventions 2

3-Month Follow-up Feedback (9 respondents) Criteria Articulation of training program objectives Meeting of training program objectives Effectiveness of teaching methods Flow and style of presentation Relevance of information to your situation Usefulness of handouts &/or training material Usefulness of examples Excellent Ratings Very Good Ratings Good Ratings Average Ratings Poor Ratings 3 4 1 0 0 3 4 1 0 0 4 3 1 0 0 3 4 1 0 0 3 4 1 0 0 4 3 1 0 0 3 4 1 0 0

3-Month Follow-up Feedback Reported psychotropic medication use No significant changes Anti-psychotic Anti-anxiety Responders comments Helpfulness of the training program Suggested improvements Trainings impact on staff ability to manage challenging behaviors manage challenging behaviors

Discussion Observational data does not indicate that the training program had an impact on staff interactions with residents Chart review data will indicate if there was an impact on other staff behavior Staff reported enjoying content and delivery of the training Especially the use of in-facility examples

Discussion Model based on identifying idiosyncratic barriers to effective caregiving and guided practice More intense intervention may be needed Limited use of follow-up consultation Buy-in from administration

Contact: christinagarrisondiehn@gmail.com

References Agency of Healthcare Research and Quality (2007). Efficacy and comparative effectiveness of off-label use of atypical anti-psychotics [publication no. 07-EHC003-EF]. Rockville (MD): Agency of Healthcare Research and Quality. Ballard C. & Waite J. (2006). The effectiveness of atypical antipsychotics for the treatment of aggression Ballard, C., Hanney, M.L., Douglas, S., McShane, R., Kossakowski, K., et al. (2009). The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomized placebo-controlled trial. The Lancet Neurology, 8, 151-157. Ballard, C.G. & Margallo-Lana, M.L. (2004). The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities. Journal of Clinical Psychiatry, 65(11), 23-28. Buchanan, J.A., & Fisher, J.E. (2002). Functional assessment and noncontingent reinforcement in the treatment of disruptive vocalization in elderly dementia patients. Journal of Applied Behavior Analysis, 35, 68-72 for improving discussions with families prior to the transition. The Gerontologist, 46, 52-61. Burgio, L.D., & Stevens, A.B. (1999). Behavioral interventions and motivational systems in the nursing home. In R. Schulz, G. Maddox, & M.P. Lawton (Eds.), Annual review of gerontology and geriatrics: Vol. 18. Focus on interventions research with older adults (pp.284-320). New York: Springer Cohen-Mansfield J, & Werner, P. (1998). The effects of an enhanced environment on nursing home residents who pace. Gerontologist 38(2), 199-208 Dawson, P., Wells, D.L., & Kline, K. (1993). related dementias. New York: Springer.

References Eaker, E.D., Vierkant, R.A., & Mickel S.F. (2002). Predictors of nursing home admission and/or death in -based study. Journal of Clinical Epidemiology, 55: 462-8. Lyketsos, C. G.,Lopez, O., Jones, B., Fitzpatrick, A.L., Breitner, J., Dekosy, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. Journal of the American Medical Association, 288, 1475-1483. Margallo- pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. International Journal of Geriatric Psychiatry, 16, 39-44. Mitchell, S.L., Kiely, D.K., Hamel, M.B. (2004). Dying with advanced dementia in the nursing home. Archives of Internal Medicine, 164, 321-3 Ronchon, P.A., Stukel, T.A., Bronskill, S.E., Gomes, T., Sykora, K. et al. (2008). Variation in nursing home antipsychotic prescribing rates. Archives of Internal Medicine, 167(7), 676-683. Schneider, L.S., Tariot, P.N., Dagerman, K.S., Davis, S.M., Hsiao, J.K., et al. (2006). Effectiveness of The New England Journal of Medicine, 355, 1525-1538. Xu, J., Kochanek, K.D. & Tejada-Vera, B. (2009). Deaths: Preliminary Data for 2007. National Vital Statistics Reports 58(1). Hyattsville, Md.: National Center for Health Statistics. Yury, C., & Fisher, J.E. (2007). Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioral problems in persons with dementia. Psychotherapy and Psychosomatics, 76, 213-218.